Shotaro Sakka
Tsukuba, 3058575, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Co-overexpression of ELOVL2 and ELOVL5 promotes clear cell renal cell carcinoma progression through LIMK1-mediated cytoskeletal reorganization.
Journal: Scientific reports
Published: March 02, 2026
Inhibition of ELOVL6 activity impairs mitochondrial respiratory function and inhibits tumor progression in FGFR3-mutated bladder cancer cells.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 06, 2025
Phospholipase D2 downregulates interleukin-1β secretion from tumor-associated macrophages to suppress bladder cancer progression.
Journal: Cancer science
Published: July 08, 2024
Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan.
Journal: International journal of clinical oncology
Published: May 13, 2024
Retroperitoneal sarcoma: a 10-year follow-up analysis using hospital-based cancer registry data in Japan.
Journal: Japanese journal of clinical oncology
Published: December 19, 2023
Adult genitourinary sarcoma: analysis using hospital-based cancer registry data in Japan.
Journal: BMC cancer
Published: December 01, 2023
Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: June 07, 2022
Laparoendoscopic single-site surgery for urachal remnant with extraperitoneal approach through a suprapubic port.
Journal: Asian journal of endoscopic surgery
Published: January 23, 2022
Clinicopathological features of adrenal malignancies: Analysis of hospital-based cancer registry data in Japan.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: November 05, 2021
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
Journal: Oncology reports
Published: May 27, 2021
Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity.
Journal: Prostate international
Published: October 01, 2018
Last Updated: 09/26/2026